Percutaneous balloon dilation of severe pulmonary valve stenosis in patients with cyanosis and congestive heart failure

2014 ◽  
Vol 84 (2) ◽  
pp. E7-E15 ◽  
Author(s):  
Endale Tefera ◽  
Shakeel A. Qureshi ◽  
Ramón Bermudez-Cañete ◽  
Lola Rubio
2019 ◽  
Vol 29 (09) ◽  
pp. 1211-1213
Author(s):  
Shintaroh Koizumi ◽  
Kozo Matsuo ◽  
Masashi Kabasawa

AbstractA 42-year-old man was referred to our hospital with heart failure and unoperated tricuspid atresia with pulmonary valve stenosis. His condition was initially managed with medical therapy; however, he required repeat hospitalisations for congestive heart failure. We diagnosed the chief cause of his heart failure as aortic valve regurgitation secondary to aortic root dilatation. Aortic root replacement was performed and then his heart failure was controlled.


2021 ◽  
Vol 9 (9) ◽  
Author(s):  
Dan Yin ◽  
Xiaoyun Wu ◽  
Ping Xiang ◽  
Yu Zhang ◽  
Jie Tian ◽  
...  

1988 ◽  
Vol 11 (2) ◽  
pp. 111-116 ◽  
Author(s):  
Patricia E. Burrows ◽  
Lee N. Benson ◽  
Jeffrey S. Smallhorn ◽  
C. A. Frederic Moes ◽  
Robert M. Freedom ◽  
...  

2017 ◽  
Vol 27 (7) ◽  
pp. 1314-1322
Author(s):  
Petra Loureiro ◽  
Barbara Cardoso ◽  
Inês B. Gomes ◽  
José F. Martins ◽  
Fátima F. Pinto

AbstractIntroductionPercutaneous balloon valvuloplasty is the primary treatment for critical pulmonary valve stenosis in neonates. Thus far, a few studies have reported long-term results of this technique in neonatal critical pulmonary valve stenosis.MethodsWe carried out a retrospective study of all consecutive newborns with critical pulmonary valve stenosis subjected to percutaneous balloon valvuloplasty at a single centre, between 1994 and 2014, to assess its immediate and long-term safety and efficacy.ResultsA total of 24 neonates presented with critical pulmonary valve stenosis. The mean diameter of the pulmonary annulus was 7 mm (±1.19); 33.3% had a dysplastic pulmonary valve, and 92% were started on prostaglandin E1 treatment. Percutaneous balloon valvuloplasty was performed at a mean age of 4.0±4.3 days using, on average, a balloon-to-pulmonary annulus ratio of 1.18 mm (with a range from 0.9 to 1.43). Immediate success was achieved in 22/24 patients (92%) with a reduction in the pulmonary transvalvular peak gradient (p<0.05) and in the right ventricle/systemic pressure ratio (p<0.05). There was one death (4%) 6 days after the procedure, and 29.2% of them had transient rhythm complications. For a mean follow-up time of 8.4 years, the re-intervention rate was 42.9%. In total, 14 re-interventions were performed in nine neonates, including surgery in six. Freedom from re-intervention was 50% at 8 years and 43% at 10 and 15 years.ConclusionThis series, to the best of our knowledge, has had the longest follow-up of neonates with critical pulmonary valve stenosis. Percutaneous balloon valvuloplasty is a safe and effective treatment, and in our study 75% of the patients were exclusively treated using this technique.


1982 ◽  
Vol 307 (9) ◽  
pp. 540-542 ◽  
Author(s):  
Jean S. Kan ◽  
Robert I. White ◽  
Sally E. Mitchell ◽  
Timothy J. Gardner

Heart ◽  
1985 ◽  
Vol 54 (4) ◽  
pp. 435-441 ◽  
Author(s):  
I D Sullivan ◽  
P J Robinson ◽  
F J Macartney ◽  
J F Taylor ◽  
P G Rees ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document